Lombard Odier Asset Management (Usa) Corp Silence Therapeutics PLC Transaction History

Lombard Odier Asset Management (Usa) Corp

$1.19 Billion
Q1 2025

A detailed history of Lombard Odier Asset Management (Usa) Corp transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Lombard Odier Asset Management (Usa) Corp holds 1,849,734 shares of SLN stock, worth $9.88 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

1,849,734

Previous 1,856,023 0.34%

Holding current value

$9.88 Million

Previous $12.8 Million 59.15%

% of portfolio

0.44%

Previous 1.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$2.82 - $7.41 $17,734 - $46,601	-6,289 Reduced 0.34%	1,849,734 $5.22 Million
Q4 2024 Feb 14, 2025	SELL	$6.33 - $19.65 $5.11 Million - $15.9 Million	-808,054 Reduced 30.33%	1,856,023 $12.8 Million
Q3 2024 Nov 14, 2024	BUY	$15.53 - $21.74 $4.01 Million - $5.61 Million	258,079 Added 10.73%	2,664,077 $48.5 Million
Q2 2024 Aug 14, 2024	BUY	$18.31 - $23.91 $312,844 - $408,526	17,086 Added 0.72%	2,405,998 $45.7 Million
Q1 2024 May 15, 2024	SELL	$17.39 - $26.25 $25.9 Million - $39.1 Million	-1,490,261 Reduced 38.42%	2,388,912 $51.6 Million
Q4 2023 Feb 14, 2024	SELL	$6.7 - $17.67 $1.2 Million - $3.16 Million	-178,759 Reduced 4.41%	3,879,173 $67.4 Million
Q3 2023 Nov 14, 2023	SELL	$5.07 - $10.74 $316,793 - $671,078	-62,484 Reduced 1.52%	4,057,932 $39.8 Million
Q2 2023 Aug 14, 2023	BUY	$4.61 - $7.44 $743,662 - $1.2 Million	161,315 Added 4.07%	4,120,416 $22.7 Million
Q1 2023 May 15, 2023	BUY	$6.2 - $15.61 $516,875 - $1.3 Million	83,367 Added 2.15%	3,959,101 $24.5 Million
Q4 2022 Feb 14, 2023	SELL	$9.69 - $17.09 $202,143 - $356,514	-20,861 Reduced 0.54%	3,875,734 $59.1 Million
Q3 2022 Nov 14, 2022	BUY	$2.65 - $29.85 $345,098 - $3.89 Million	130,226 Added 3.46%	3,896,595 $35.7 Million
Q2 2022 Aug 15, 2022	BUY	$7.99 - $19.5 $1.07 Million - $2.62 Million	134,135 Added 3.69%	3,766,369 $38.2 Million
Q1 2022 May 16, 2022	BUY	$16.5 - $23.89 $2.64 Million - $3.82 Million	159,713 Added 4.6%	3,632,234 $55.7 Million
Q4 2021 Feb 18, 2022	BUY	$20.61 - $25.71 $27.6 Million - $34.4 Million	1,337,771 Added 62.67%	3,472,521 $83 Million
Q4 2021 Feb 14, 2022	BUY	$20.61 - $25.71 $31.7 Million - $39.5 Million	1,536,609 Added 256.9%	2,134,750 $40.9 Million
Q3 2021 Nov 12, 2021	SELL	$20.61 - $26.87 $6.49 Million - $8.46 Million	-314,993 Reduced 34.5%	598,141 $10.7 Million
Q2 2021 Aug 13, 2021	SELL	$22.34 - $28.35 $6.37 Million - $8.08 Million	-285,007 Reduced 23.79%	913,134 $21.6 Million
Q1 2021 May 17, 2021	BUY	$21.8 - $28.01 $14.3 Million - $18.4 Million	658,141 Added 121.88%	1,198,141 $24.4 Million
Q3 2020 Nov 16, 2020	BUY	$17.31 - $19.5 $9.35 Million - $10.5 Million	540,000 New	540,000 $8.1 Million

Others Institutions Holding SLN

# of Institutions

Shares Held

22.7M

Call Options Held

1.3K

Put Options Held

2.6K

View Full List

About Silence Therapeutics plc

Ticker SLN
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,888,400
Market Cap $192M
Description
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...

More about SLN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.

Account

Lombard Odier Asset Management (Usa) Corp Silence Therapeutics PLC Transaction History